학술논문
Efficacy and Safety of Oral Topotecan and Bevacizumab Combination as Second-Line Treatment for Relapsed Small-Cell Lung Cancer: An Open-Label Multicenter Single-Arm Phase II Study
Document Type
Article
Source
In Clinical Lung Cancer July 2013 14(4):356-363
Subject
Language
ISSN
1525-7304